Peng Zhang, PhD

Trials

Studies that name Peng Zhang, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:44 UTC. Open this list on ClinicalTrials.gov

• Ph3
  NCT07863999 · Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Combined With Monoclonal Antibody in Locally Advanced NSCLC

  Shanghai Pulmonary Hospital, Shanghai, China · recruiting · Locally Advanced Non-Small Cell Lung Cancer · principal investigator
• Ph2
  NCT06837948 · Neoadjuvant Chemotherapy Combined With Bispecific Antibody Versus Monoclonal Antibody in Locally Advanced NSCLC

  Shanghai Pulmonary Hospital, Shanghai, China · not yet recruiting · Locally Advanced Non-Small Cell Lung Cancer · principal investigator
• Ph2
  NCT05891080 · Neoadjuvant Therapy With Toripalimab and JS004 Combined With Platinum-based Doublet Chemotherapy for Resectable or Potentially Resectable Stage III Non-small Cell Lung Cancer: A Randomised Controlled, Open-label, Phase 2 Trial

  Shanghai Pulmonary Hospital, Shanghai, China · not yet recruiting · Stage III Non-small Cell Lung Cancer · principal investigator
• N/A
  NCT05857800 · Exploring the Neo-Adjuvant Therapy Effects on Lung Cancer Through Monitoring and Assessment of Tumor Environment

  Shanghai Pulmonary Hospital, Shanghai, China · recruiting · Lung Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:44 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.